S. Gejalakshmi, N. Harikrishnan, Anas S. Mohameid
S. Gejalakshmi1, N. Harikrishnan1, Anas S. Mohameid2
1Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Velappanchavadi, Chennai-77, Tamil Nadu 600095, India.
2Faculty of Pharmacy, Omar Al Mukthar University, Al - Bayda, Libya.
Volume - 13,
Issue - 3,
Year - 2021
Background: Diabetes mellitus is a metabolic condition characterized by elevated blood glucose levels in the bloodstream. It occurs due to the inadequate amount of insulin secreted in the body or resistance of insulin receptors. Objective: In the present study, for its effect on alpha-amylase and alpha-glucosidase enzymes, Oroxylum indicuma flavone glycoside was assessed using in-vitro assays by removing the respective enzymes from whole wheat and barley in conjunction with in-silico analysis. Method: in-vitro alpha amylase inhibitory activity and in-vitro alpha glucosidase inhibitory activity was performed using acarbose as a standard drug. The molecular docking study was performed using Schrodinger (Maestro V 11.5) software. The parameters glide score, Lipinski rule for drug likeliness, bioactive scoring and ADME properties were assessed in the docking study. In addition, baicalein's antioxidant function was assessed using DPPH assay, nitric oxide scavenging activity. The cytotoxicity of Oroxylum indicumwas evaluated using the Brine shrimp lethality assay. Results: The alpha-amylase assay performed showed IC50 value of 48.40 µg/ml for Oroxylum indicumwhereas alpha-glucosidase assay showed an IC50 value of 16.03 µg/ml. Oroxylum indicumshows the glide score of-5.565 with 5EOF and glide score of -5.339 with 5NN8 in the molecular docking study. The highest percentage of DPPH radical scavenging activity and nitrous oxide scavenging activity were found to be.27% at160 µg/ml and 50.02% at the concentrations of 160 µg/ml respectively. Conclusion: Based on further in vivo and clinical trials, Oroxylum indicummay be used for the management of hyperglycaemia.
Cite this article:
S. Gejalakshmi, N. Harikrishnan, Anas S. Mohameid. In-Vitro and In-Silico Alpha Glucucosidase Inhibitory activity of Oroxylum indicum. Research Journal of Pharmacognosy and Phytochemistry. 2021; 13(3):119-5. doi: 10.52711/0975-4385.2021.00020
S. Gejalakshmi, N. Harikrishnan, Anas S. Mohameid. In-Vitro and In-Silico Alpha Glucucosidase Inhibitory activity of Oroxylum indicum. Research Journal of Pharmacognosy and Phytochemistry. 2021; 13(3):119-5. doi: 10.52711/0975-4385.2021.00020 Available on: https://rjpponline.org/AbstractView.aspx?PID=2021-13-3-3
1. Wade, D. M., Hankins, M., Smyth, D. A., Rhone, E. E., Mythen, M. G., Howell, D. C., and Weinman, J. A. (2014). Detecting acute distress and risk of future psychological morbidity in critically ill patients: validation of the intensive care psychological assessment tool. Critical Care, 18(5): 519.
2. Laoufi, H., Benariba, N., Adjdir, S., andDjaziri, R. (2017). In vitro α-amylase and α-glucosidase inhibitory activity of Ononis angustissima extracts. J. Appli. Pharm. Sci, 7(2): 191-198.
3. Vinayagam, R., and Xu, B. (2015). Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutrition and Metabolism, 12(1): 60.
4. Sama, K., Murugesan, K., andSivaraj, R. (2012). In vitro alpha amylase and alpha glucosidase inhibition activity of crude ethanol extract of Cissusarnottiana. Asian Journal of Plant Science and Research, 2(4): 550-553.
5. Proença, C., Freitas, M., Ribeiro, D., Oliveira, E. F., Sousa, J. L., and Tomé, S. M. (2017) α-Glucosidase Inhibition by Flavonoids: 1216-1228.
6. Fu, Y., Luo, J., Jia, Z., Zhen, W., Zhou, K., Gilbert, E., and Liu, D. (2014). Oroxylum indicumprotects against type 2 diabetes via promoting islet β-cell function in obese diabetic mice. International Journal of Endocrinology, 2014.
7. Waisundara, V. Y., Hsu, A., Huang, D., and Tan, B. K. H. (2008). Scutellariabaicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats. The American journal of Chinese medicine, 36(03): 517-540.
8. Zhang, B., Sun, W., Yu, N., Sun, J., Yu, X., Li, X and Dong, Y. (2018). Anti-diabetic effect of Oroxylum indicumis associated with the modulation of gut microbiota in streptozotocin and high-fat-diet induced diabetic rats. Journal of Functional Foods, 46: 256-267.
9. Nair, S. S., Kavrekar, V., and Mishra, A. (2013). In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. European Journal of Experimental Biology, 3(1): 128-132.
10. Stark, J. R., and Yin, X. S. (1987). Evidence for the Presence of Maltase and Α‐Glucosidase Isoenzymes in Barley. Journal of the Institute of Brewing, 93(2): 108-112.
11. Mahrous, R., Ghareeb, D. A., Fathy, H. M., EL-Khair, R. M. A., and Omar, A. A. (2017). The protective effect of Egyptian Withaniasomnifera against Alzheimer’s. Med. Aromat Plants, 6(285): 2167-0412.
12. McLaughlin, J. L. (1982). Brine shrimp: a convenient general bioassay for active constituents. Planta Med, 45: 31-32.
13. Sarah, Q. S., Anny, F. C., and Mir, M. (2017). Brine shrimp lethality assay. Bangladesh Journal of Pharmacology, 12(2): 186-189.
14. Nachammai, V., Srikanth, J., Lavanya, R., Reddy, C., andMaheswara, U. (2018). In-vitro and in Silico Alpha Amylase and Alpha-Glucosidase Inhibitory Activity of Emblica officinalis. Research Journal of Pharmaceutical Biological and Chemical Sciences, 9(5): 1784-1794.
15. Barua, J., Sany, M. A., Barua, L., Hossen, M., Absar, N., Hossain, Z andAkther, S. (2019). Insilico molecular docking of some isolated selected compounds of Phoenix Sylvestris (L.) against Diabetes. Biomedical Journal of Scientific and Technical Research, 16(2): 11883-11886.
16. Md, R. A. (2018). In silico Molecular Docking and ADME/T Analysis of Some Selected Isolated Compounds of Phyllanthus emblica against Type 2 Diabetics. American Journal of Ethnomedicine, 5(2): 9.
17. Singh, J., and Kakkar, P. (2013). Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats. Food and Chemical Toxicology, 62: 722-731.
18. Nik Salleh, N. N. H., Othman, F. A., Kamarudin, N. A., and Tan, S. C. (2020). The Biological Activities and Therapeutic Potentials of Oroxylum indicumExtracted from Oroxylum indicum: A Systematic Review. Molecules, 25(23): 5677.